-
Health and social responses to drug problems in Europe (EMCDDA 2021 Statistical Bulletin)
Health and social responses data reported here comprises information on the availability of different types of needle and syringe programmes (NSPs) in the country, including prison-,...
HTML
-
Drug-related infectious diseases in Europe (EMCDDA 2021 Statistical Bulletin) Duplicated
Drug-related infectious diseases such as HIV and hepatitis B and C are among the most serious health consequences of drug use. Even in countries where HIV prevalence in injecting drug...
HTML
-
Drug overdose deaths in Europe (EMCDDA 2021 Statistical Bulletin)
Drug-related mortality is a complex phenomenon, which accounts for a considerable percentage of deaths among young people in many European countries. The EMCDDA, in collaboration with...
HTML
-
Prevalence of drug use in Europe (EMCDDA 2021 Statistical Bulletin)
Prevalence and patterns of drug use in the general population (adults or school children) is assessed through surveys based on representative probabilistic samples of the whole population...
HTML (1 Nedladdningar)
-
Prevalence of drug use in Europe (EMCDDA 2022 Statistical Bulletin)
Prevalence and patterns of drug use in the general population (adults or school children) is assessed through surveys based on representative probabilistic samples of the whole population...
HTML
-
Problem drug use in Europe (EMCDDA 2022 Statistical Bulletin)
‘Problem drug use’ is defined by the EMCDDA as ‘injecting drug use or long duration / regular use of opioids, cocaine and/or amphetamines’. This definition specifically includes regular...
HTML
-
Drug treatment demand in Europe (EMCDDA 2022 Statistical Bulletin)
Information on the number of people entering treatment for a drug problem provides insight into general trends in problem drug use and also offers a perspective on the organisation and...
HTML
-
Health and social responses to drug problems in Europe (EMCDDA 2022 Statistical Bulletin)
Health and social responses data reported here comprises information on the availability of different types of needle and syringe programmes (NSPs) in the country, including prison-,...
HTML
-
Drug-related infectious diseases in Europe (EMCDDA 2022 Statistical Bulletin)
Drug-related infectious diseases such as HIV and hepatitis B and C are among the most serious health consequences of drug use. Even in countries where HIV prevalence in injecting drug...
HTML
-
Health and social responses to drug problems in Europe (EMCDDA 2023 Statistical Bulletin)
Health and social responses data reported here comprises information on the availability of different types of needle and syringe programmes (NSPs) in the country, including prison-,...
HTML
Visa denna dataserie med Infographic. Coverage of opioid agonist treatment in 2021 or the most recent year and in the previous estimate , Infographic. Needle and syringe distribution and opioid agonist treatment coverage in relation to WHO 2020 targets , Infographic. Number of European countries implementing opioid agonist treatment, up to 2022 , Infographic. Clients in opioid agonist treatment
-
Drug-related infectious diseases in Europe (EMCDDA 2023 Statistical Bulletin)
Drug-related infectious diseases such as HIV and hepatitis B and C are among the most serious health consequences of drug use. Even in countries where HIV prevalence in injecting drug...
HTML
Visa denna dataserie med Interactive map. Most-recent HIV outbreaks in Europe among people who inject drugs , New HIV notifications linked to injecting drug use in the European Union, 2009 to 2021 , Infographic. Drug-related infectious diseases
-
Drug treatment demand in Europe (EMCDDA 2023 Statistical Bulletin)
Information on the number of people entering treatment for a drug problem provides insight into general trends in problem drug use and also offers a perspective on the organisation and...
HTML
Visa denna dataserie med Infographic. Cannabis users entering treatment in Europe , Infographic. Methamphetamine users entering treatment in Europe , Infographic. Amphetamine users entering treatment for in Europe , Infographic. Cocaine users entering treatment in Europe , Trends in injecting among first-time treatment entrants with heroin, cocaine, amphetamine or methamphetamine as primary drug: proportion reporting injecting as main route of administration , Infographic. Synthetic cathinone users entering treatment in Europe
-
Drug-induced deaths in Europe (EMCDDA 2023 Statistical Bulletin)
Drug-related mortality is a complex phenomenon, which accounts for a considerable percentage of deaths among young people in many European countries. The EMCDDA, in collaboration with...
HTML
Visa denna dataserie med Trends in drug-induced deaths in the European Union, Norway and Türkiye , Age distribution of drug-induced deaths reported in the European Union, Norway and Türkiye in 2021 (percent)
-
Prevalence of drug use in Europe (EMCDDA 2023 Statistical Bulletin)
Prevalence and patterns of drug use in the general population (adults or school children) is assessed through surveys based on representative probabilistic samples of the whole population...
HTML
Visa denna dataserie med Dashboard. Prevalence of cannabis use in Europe , Dashboard. Prevalence of MDMA use in Europe , Dashboard. Prevalence of cocaine use in Europe , Dashboard. Prevalence of amphetamines use in Europe
-
Problem drug use in Europe (EMCDDA 2023 Statistical Bulletin)
‘Problem drug use’ is defined by the EMCDDA as ‘injecting drug use or long duration / regular use of opioids, cocaine and/or amphetamines’. This definition specifically includes regular...
HTML
Visa denna dataserie med Estimated number and prevalence of people who inject drugs, by country, 2015 to 2021